Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Baxter
McKesson
Express Scripts
Harvard Business School

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Key Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for KEY PHARMS, and what generic and branded alternatives to KEY PHARMS drugs are available?

KEY PHARMS has two approved drugs.



Summary for Key Pharms
US Patents:0
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Key Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Key Pharms GENAPAX gentian violet TAMPON;VAGINAL 085017-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Key Pharms QUINORA quinidine sulfate TABLET;ORAL 083576-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
AstraZeneca
Moodys
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.